106 related articles for article (PubMed ID: 11896751)
1. Acceleration of chromosomal instability of BRCA1-associated hereditary breast cancers by p53 abnormality.
Miyoshi Y; Iwao K; Ikeda N; Egawa C; Noguchi S
Breast J; 2002; 8(2):77-80. PubMed ID: 11896751
[TBL] [Abstract][Full Text] [Related]
2. Acceleration of chromosomal instability by loss of BRCA1 expression and p53 abnormality in sporadic breast cancers.
Miyoshi Y; Iwao K; Takahashi Y; Egawa C; Noguchi S
Cancer Lett; 2000 Oct; 159(2):211-6. PubMed ID: 10996734
[TBL] [Abstract][Full Text] [Related]
3. Human BRCA1-associated breast cancer: no increase in numerical chromosomal instability compared to sporadic tumors.
Focken T; Steinemann D; Skawran B; Hofmann W; Ahrens P; Arnold N; Kroll P; Kreipe H; Schlegelberger B; Gadzicki D
Cytogenet Genome Res; 2011; 135(2):84-92. PubMed ID: 22024613
[TBL] [Abstract][Full Text] [Related]
4. Association of loss of BRCA1 expression with centrosome aberration in human breast cancer.
Shimomura A; Miyoshi Y; Taguchi T; Tamaki Y; Noguchi S
J Cancer Res Clin Oncol; 2009 Mar; 135(3):421-30. PubMed ID: 18813953
[TBL] [Abstract][Full Text] [Related]
5. Mammary tumors in mice conditionally mutant for Brca1 exhibit gross genomic instability and centrosome amplification yet display a recurring distribution of genomic imbalances that is similar to human breast cancer.
Weaver Z; Montagna C; Xu X; Howard T; Gadina M; Brodie SG; Deng CX; Ried T
Oncogene; 2002 Aug; 21(33):5097-107. PubMed ID: 12140760
[TBL] [Abstract][Full Text] [Related]
6. Molecular profile and clinical variables in BRCA1-positive breast cancers. A population-based study.
Musolino A; Michiara M; Bella MA; Naldi N; Zanelli P; Bortesi B; Capelletti M; Soldani L; Camisa R; Martella E; Franciosi V; Savi M; Neri TM; Ardizzoni A; Cascinu S
Tumori; 2005; 91(6):505-12. PubMed ID: 16457150
[TBL] [Abstract][Full Text] [Related]
7. p53 inactivation is a rare event in familial breast tumors negative for BRCA1 and BRCA2 mutations.
Sensi E; Tancredi M; Aretini P; Cipollini G; Naccarato AG; Viacava P; Bevilacqua G; Caligo MA
Breast Cancer Res Treat; 2003 Nov; 82(1):1-9. PubMed ID: 14672397
[TBL] [Abstract][Full Text] [Related]
8. High incidence of protein-truncating TP53 mutations in BRCA1-related breast cancer.
Holstege H; Joosse SA; van Oostrom CT; Nederlof PM; de Vries A; Jonkers J
Cancer Res; 2009 Apr; 69(8):3625-33. PubMed ID: 19336573
[TBL] [Abstract][Full Text] [Related]
9. Genomic deletions in the BRCA1, BRCA2 and TP53 regions associate with low expression of the estrogen receptor in sporadic breast carcinoma.
Schmutzler RK; Bierhoff E; Werkhausen T; Fimmers R; Speiser P; Kubista E; Krebs D; Zeillinger R; Wiestler OD; Von Deimling A
Int J Cancer; 1997 Jun; 74(3):322-5. PubMed ID: 9221812
[TBL] [Abstract][Full Text] [Related]
10. p53 abnormality and chromosomal instability in the same breast tumor cells.
Sigurdsson S; Bödvarsdottir SK; Anamthawat-Jonsson K; Steinarsdottir M; Jonasson JG; Ogmundsdottir HM; Eyfjörd JE
Cancer Genet Cytogenet; 2000 Sep; 121(2):150-5. PubMed ID: 11063799
[TBL] [Abstract][Full Text] [Related]
11. Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.
Hedau S; Jain N; Husain SA; Mandal AK; Ray G; Shahid M; Kant R; Gupta V; Shukla NK; Deo SS; Das BC
Breast Cancer Res Treat; 2004 Nov; 88(2):177-86. PubMed ID: 15564800
[TBL] [Abstract][Full Text] [Related]
12. X inactive-specific transcript RNA coating and genetic instability of the X chromosome in BRCA1 breast tumors.
Vincent-Salomon A; Ganem-Elbaz C; Manié E; Raynal V; Sastre-Garau X; Stoppa-Lyonnet D; Stern MH; Heard E
Cancer Res; 2007 Jun; 67(11):5134-40. PubMed ID: 17545591
[TBL] [Abstract][Full Text] [Related]
13. Genetic alterations in early-onset invasive breast carcinomas: correlation of c-erbB-2 amplification detected by fluorescence in situ hybridization with p53 accumulation and tumor phenotype.
Fiche M; Avet-Loiseau H; Heymann MF; Moussaly F; Digabel C; Joubert M; Classe JM; Dravet F; Fumoleau P; Ross J; Maugard CM
Int J Cancer; 1999 Oct; 84(5):511-5. PubMed ID: 10502729
[TBL] [Abstract][Full Text] [Related]
14. Molecular-cytogenetic analysis of HER-2/neu gene in BRCA1-associated breast cancers.
Grushko TA; Blackwood MA; Schumm PL; Hagos FG; Adeyanju MO; Feldman MD; Sanders MO; Weber BL; Olopade OI
Cancer Res; 2002 Mar; 62(5):1481-8. PubMed ID: 11888924
[TBL] [Abstract][Full Text] [Related]
15. miRNA expression patterns in normal breast tissue and invasive breast cancers of BRCA1 and BRCA2 germ-line mutation carriers.
Vos S; Vesuna F; Raman V; van Diest PJ; van der Groep P
Oncotarget; 2015 Oct; 6(31):32115-37. PubMed ID: 26378051
[TBL] [Abstract][Full Text] [Related]
16. MYC is amplified in BRCA1-associated breast cancers.
Grushko TA; Dignam JJ; Das S; Blackwood AM; Perou CM; Ridderstråle KK; Anderson KN; Wei MJ; Adams AJ; Hagos FG; Sveen L; Lynch HT; Weber BL; Olopade OI
Clin Cancer Res; 2004 Jan; 10(2):499-507. PubMed ID: 14760071
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations: differences from breast carcinomas arising in BRCA1 and BRCA2 mutation carriers.
Palacios J; Honrado E; Osorio A; Cazorla A; Sarrió D; Barroso A; Rodríguez S; Cigudosa JC; Diez O; Alonso C; Lerma E; Sánchez L; Rivas C; Benítez J
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3606-14. PubMed ID: 14506147
[TBL] [Abstract][Full Text] [Related]
18. Determining true HER2 gene status in breast cancers with polysomy by using alternative chromosome 17 reference genes: implications for anti-HER2 targeted therapy.
Tse CH; Hwang HC; Goldstein LC; Kandalaft PL; Wiley JC; Kussick SJ; Gown AM
J Clin Oncol; 2011 Nov; 29(31):4168-74. PubMed ID: 21947821
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous detection of p53 nuclear protein and chromosome aberrations on sections from formalin-fixed, paraffin-embedded breast cancer tissue.
Bödvarsdóttir SK; Sigurdsson S; Steinarsdóttir M; Eyfjörd JE; Ogmundsdóttir H; Anamthawat-Jónsson K
Chromosome Res; 1998 Apr; 6(3):233-5. PubMed ID: 9609668
[No Abstract] [Full Text] [Related]
20. Allelic loss at BRCA1, BRCA2, and adjacent loci in relation to TP53 abnormality in breast cancer.
Tseng SL; Yu IC; Yue CT; Chang SF; Chang TM; Wu CW; Shen CY
Genes Chromosomes Cancer; 1997 Dec; 20(4):377-82. PubMed ID: 9408754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
